Psychiatry and Neurology, Neurology · Kirkland, WA
NPI
1073750105
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
12039 NE 128th St, Suite 300
Kirkland, WA, 98034
Phone (425) 899-3123
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
1,141 services
Medicare patients, 2024
246
Average age 76
Drug cost, 2024
$1.7M
4,031 prescriptions
Company payments, 2025
$1,151
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel J Burdick was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 445 times for 217 patients. In total Daniel J Burdick billed 1,141 services in 22 codes, and Medicare paid $58K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 445 | 217 | $12.33 | $5,487 |
| 99214 Office E&M - Established | Facility | 365 | 180 | $70.17 | $26K |
| 99215 Office E&M - Established | Facility | 101 | 77 | $107.11 | $11K |
| 99213 Office E&M - Established | Facility | 54 | 45 | $48.72 | $2,631 |
| 99205 Office E&M - New | Facility | 32 | 32 | $137.58 | $4,403 |
| 95970 Electrical Nerve Conductivity | Facility | 26 | 16 | $11.20 | $291 |
| 99483 Office/Outpatient Services | Facility | 17 | 17 | $128.26 | $2,181 |
| 99204 Office E&M - New | Facility | 15 | 15 | $104.72 | $1,571 |
By year: 2022 $65K for 838 services; 2023 $64K for 814 services; 2024 $58K for 1,141 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel J Burdick prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 992 prescriptions and refills. In total Daniel J Burdick wrote 4,031 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 992 | 2,466 | 267 | $37K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 497 | 1,228 | 131 | $35K |
| Rytary Carbidopa/Levodopa | 231 | 409 | 48 | $374K |
| Donepezil Hcl Generic | 174 | 427 | 53 | $2,055 |
| Quetiapine Fumarate Generic | 147 | 244 | 30 | $3,098 |
| Rasagiline Mesylate Generic | 143 | 381 | 45 | $21K |
| Nuplazid Pimavanserin Tartrate | 136 | 156 | 19 | $770K |
| Ropinirole Hcl Generic | 112 | 290 | 29 | $4,337 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 103 | 300 | 34 | $3,104 |
| Midodrine Hcl Generic | 100 | 134 | 17 | $5,132 |
| Gabapentin Generic | 95 | 229 | 30 | $2,048 |
| Amantadine Amantadine Hcl | 87 | 230 | 29 | $5,825 |
| Fludrocortisone Acetate Generic | 85 | 150 | 18 | $3,338 |
| Selegiline Hcl Generic | 80 | 197 | 20 | $10K |
| Rivastigmine Rivastigmine Tartrate | 71 | 128 | 21 | $5,271 |
Brand drugs: 577 claims; generic drugs: 3,454 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel J Burdick $1,151 ($1,151 in general payments such as food, travel and fees) from 24 companies. The largest payer was Boston Scientific Corporation with $257.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 4 | $257 |
| Abbvie Inc. ABBV | 4 | $121 |
| Merz Pharmaceuticals, LLC | 4 | $120 |
| TG Therapeutics, Inc. TGTX | 4 | $91.14 |
| Janssen Biotech, Inc. JNJ | 2 | $53.69 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $44.25 |
| Abbott Laboratories ABT | 1 | $43.16 |
| CSL Behring CSL.AX | 2 | $42.95 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $41.55 |
| Amgen Inc. AMGN | 2 | $34.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.